Is it safe to take brexpiprazole (Rexulti) 2 mg together with bupropion XL (Wellbutrin) 150 mg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, taking Rexulti (brexpiprazole) 2mg with Wellbutrin XL (bupropion) 150mg is safe and appropriate.

This combination is explicitly supported by FDA labeling and clinical evidence, with no dosage adjustment required when these medications are used together. The FDA drug label for Rexulti specifically states that no dosage adjustment is needed for substrates of CYP2B6 (which includes bupropion) when administered concomitantly with brexpiprazole 1.

Key Safety Considerations

Drug Interaction Profile

  • No pharmacokinetic interaction exists between these medications. Brexpiprazole does not significantly affect bupropion metabolism, and bupropion does not alter brexpiprazole levels 1, 2
  • In vitro studies confirm brexpiprazole has only weak inhibitory effects on CYP2B6 (the enzyme that metabolizes bupropion), with an IC50 of 8.19 μmol/L—far above clinically relevant concentrations 2

Clinical Context

This combination is commonly used in two scenarios:

For Major Depressive Disorder (MDD):

  • Rexulti is FDA-approved as an adjunctive treatment to antidepressants for MDD 1
  • Clinical trials specifically included patients taking various antidepressants, including bupropion 3, 4
  • Studies demonstrate that brexpiprazole 2mg effectively augments antidepressant therapy with a favorable tolerability profile 4, 5

For patients switching from other medications:

  • Case series data show patients who had insufficient outcomes with bupropion alone may benefit from adding or switching to brexpiprazole 3

Important Monitoring Points

Seizure Risk

  • Bupropion lowers seizure threshold, particularly at doses above 300mg/day 6
  • Your 150mg dose is well below the concerning threshold
  • Bupropion is contraindicated in patients with seizure disorders, eating disorders (bulimia/anorexia), or abrupt alcohol/benzodiazepine withdrawal 6
  • Brexpiprazole does not increase seizure risk 7

Neuropsychiatric Monitoring

  • Both medications carry warnings about monitoring for worsening depression or suicidal ideation, particularly in patients under 24 years old 1
  • Watch for new or worsening mood changes, especially in the first few weeks of treatment

Metabolic Effects

  • Brexpiprazole can cause weight gain, increased blood sugar, and lipid abnormalities 1
  • Bupropion is generally weight-neutral or associated with modest weight loss 8
  • Monitor weight, blood glucose, and lipid panels periodically

Common Side Effects to Expect

From Rexulti: Akathisia (restlessness), weight gain, drowsiness, headache 1

From Wellbutrin: Insomnia, dry mouth, headache, nausea, increased blood pressure 6, 8

Practical Recommendations

  • Take Wellbutrin XL in the morning to minimize insomnia risk 8
  • Rexulti can be taken once daily with or without food, at any time of day 1
  • No dose adjustments needed for either medication when used together
  • Avoid overheating and dehydration while on Rexulti 1
  • Do not stop either medication abruptly without consulting your prescriber

When to Seek Immediate Medical Attention

Contact your healthcare provider immediately if you experience:

  • New or worsening suicidal thoughts
  • Seizures
  • High fever with muscle stiffness (neuroleptic malignant syndrome)
  • Uncontrolled movements of face, tongue, or body
  • Severe agitation or confusion
  • Signs of high blood sugar (excessive thirst, urination, fruity breath)

This combination is well-established in clinical practice and supported by both FDA labeling and clinical evidence, making it a safe and appropriate treatment regimen when properly monitored.

Related Questions

Are there evidence‑based studies supporting the use of brexpiprazole (Rexulti) as an adjunct to antidepressant therapy in veterans?
For a patient who recently started rexulti (brexpiprazole) and is aggressively hitting staff after receiving oral haloperidol, what emergency medication should be administered?
What are the approved clinical uses of brexpiprazole?
Can I start brexpiprazole (Braylar) 1.5 mg while tapering lithium 600 mg daily?
What is the recommended starting dose and titration schedule of Rexulti (brexpiprazole) for adults, including elderly patients or those with hepatic impairment?
In a patient treated for diabetic ketoacidosis who has received 48 hours of insulin infusion with resolved ketosis but persistently low serum bicarbonate, what are the possible causes of the ongoing metabolic acidosis?
Is loperamide (Imodium) appropriate for treating acute loose stool?
In a patient treated for diabetic ketoacidosis who has negative ketones after 48 hours of insulin infusion but still has persistently low bicarbonate, what could be causing the ongoing metabolic acidosis?
What is the maximum recommended daily dose of vilanterol?
Why is endocrine (estrogen‑blocking) therapy omitted in a newly diagnosed left breast carcinoma that is estrogen‑receptor positive, progesterone‑receptor positive, and HER2‑positive receiving nanoxel (nab‑paclitaxel), trastuzumab (Herceptin), and pertuzumab (Perjeta), and when can endocrine therapy be started?
What is the recommended duration of Augmentin (amoxicillin‑clavulanate) treatment for acute otitis media in an adult?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.